Synthesis and photophysical studies of a chlorin sterically designed to prevent self-aggregation
Source abstract
Abstract
The chlorins exhibit a strong absorption band around 660 nm, which suggests use in photodynamic therapy (PDT). 1 Due to the extended conjugated core structure, they often suffer self-aggregation, which is a negative point for application in PDT. In this work, we have prepared a new chlorin derivative which is self-prevented from aggregation, by a 1,3dipolar cycloaddition between a very activated porphyrin (dipolarophile) and a benzyl azomethine ylide. 2 We have also performed some preliminary photophysical studies in order to evaluate its ability to act as a photosensitizer in PDT.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Porphyrin and Phthalocyanine Chemistry · Photodynamic Therapy Research Studies · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (23)
Show source-provided references
1. Novel zinc porphyrin with phenylenevinylene meso-substituents: synthesis and application in dye-sensitized solar cells10.1016/j.jpowsour.2011.03.023 ↗
2. Enantio- and regioselective epoxidation of olefinic double bonds in quinolones, pyridones, and amides catalyzed by a ruthenium porphyrin catalyst with a hydrogen bonding site10.1021/ja305890c ↗
3. Synthesis of porphyrin-dendrimers with a pyrene in the periphery and their cubic nonlinear optical properties10.3390/molecules16086950 ↗
4. Scanning force microscopy observation of tumor cells treated with hematoporphyrin IX derivatives10.1114/1.1424923 ↗
5. The role of porphyrin chemistry in tumour imaging and photodynamic therapy10.1039/B915149B ↗
6. Photodiagnosis and treatment of condyloma acuminatum using 5-aminolevulinic acid and homemade devices10.1016/j.pdpdt.2011.09.001 ↗
7. Susceptibility of Staphylococcus aureus to porphyrin-mediated photodynamic antimicrobial chemotherapy: an in vitro study10.1007/s10103-009-0705-0 ↗
8. Comparison of photodynamic therapy versus conventional antifungal therapy for the treatment of denture stomatitis: a randomized clinical trial10.1111/j.1469-0691.2012.03933.x ↗
9. Synthesis of phthalocyanines-ALA conjugates: water-soluble compounds with low aggregation10.1021/jo901633a ↗
10. Efficient one-pot regioselective synthesis of 2,3-dibromo-5,10,15,20-tetraarylporphyrins from 5,10,15,20-tetraarylchlorins
11. Synthesis of pheophorbide-a conjugates with anticancer drugs as potential cancer diagnostic and therapeutic agents10.1016/j.bmc.2011.07.058 ↗
12. Synthesis of new amphiphilic chlorin derivatives from protoporphyrin-IX dimethyl ester10.1016/j.tet.2008.06.103 ↗
13. Synthesis of locked meso-β-substituted chlorins via 1,3-dipolar cycloaddition10.1021/jo060545x ↗
14. meso-Tetraarylporphyrins as dipolarophiles in 1,3-dipolar cycloaddition reactions10.1039/a905016g ↗
15. 1,3-Dipolar cycloaddition reaction in porphyrin systems with functionalized alkyl nitrile oxides – synthesis of isoxazoline-fused chlorins10.3987/COM-11-12347 ↗
16. Chlorin photosensitizers sterically designed to prevent self-aggregation10.1021/jo201568n ↗
17. Armarego · 2000
18. Spectral properties and absolute determination of singlet oxygen production by naphthaloporphyrins10.1016/1010-6030(94)80004-9 ↗
19. Novel organosoluble metal-free and metallophthalocyanines bearing triazolemoieties: microwave assisted synthesis and determination of photophysical and photochemical properties10.1016/j.dyepig.2012.03.026 ↗
20. Preparation of some pyrrole-3,4-dicarboxylic acid derivatives and the crystal structure of 2-methylpyrrolo[3,4-c]pyrrole-1,3(H2, 5H)-dione10.1071/CH9910323 ↗
21. Oligocyclization of 2-(hydroxymethyl)pyrroles with electron withdrawing groups at β-positions: formation and structural elucidation of porphyrinogens and hexaphyrinogens10.1039/B307132D ↗
22. Synthesis of tetraphenylporphyrins under very mild conditions10.1016/S0040-4039(00)85109-6 ↗
23. Synthesis of glycoporphyrin derivatives and their antiviral activity against herpes simplex virus types 1 and 210.1016/j.bmc.2005.04.015 ↗